Concepedia

Emily Langron

EL

Statistics

Publications

6

Citations

222

H-Index

6

Active since

2014

Affiliations

University College London(Current)

Eli Lilly (United Kingdom)

University of Parma

Rega Institute for Medical Research

Emily Langron is an author at University College London specializing in pharmacology, cystic fibrosis, and ion channel physiology.

Publications per year

2014–2019

6

Publications

6

Gain and Loss of Function of P2X<sub>7</sub> Receptors: Mechanisms, Pharmacology and Relevance to Diabetic Neuropathic Pain

Daniel Ursu, Philip J. Ebert, Emily Langron et al. · Molecular Pain · 2014 · 78 citations · Full text

Medicine, Molecular Genetics, Pharmacology +17

Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons

Jeffrey L. Dage, Ellen M. Colvin, Antoine Fouillet et al. · Psychopharmacology · 2014 · 52 citations

Life Sciences, Neuroscience, Pharmacology +16

Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases

Sabrina Tassini, Liang Sun, Kristina Lanko et al. · Journal of Medicinal Chemistry · 2017 · 29 citations

Pharmacy, Biology, Infectious Diseases +14

Potentiation of the cystic fibrosis transmembrane conductance regulator by VX‐770 involves stabilization of the pre‐hydrolytic, O<sub>1</sub> state

Emily Langron, Stella Prins, Paola Vergani · British Journal of Pharmacology · 2018 · 24 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Improved fluorescence assays to measure the defects associated with F508del‐CFTR allow identification of new active compounds

Emily Langron, Michela I. Simone, Clémence Delalande et al. · British Journal of Pharmacology · 2017 · 20 citations · Full text

Medicine, Molecular Biology, Pharmacology +15

1–5 of 6